Three galactose inducible promoters for use in C. neoformans var. grubii

Fungal Genetics and Biology

Volumn 46, Issue 1, 2009, Pages 9-16

  Ruff, Jack A ^a   Lodge, Jennifer K ^a   Baker, Lorina G ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADE2; GAL1; GAL10; GAL7; Serotype A; UGE1; UGE2 mating

Indexed keywords

FUNGAL PROTEIN; GALACTOSE; GLUCOSE; PROTEIN GAL1; PROTEIN GAL7; PROTEIN UGE2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; GENE CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

CRYPTOCOCCUS NEOFORMANS; GALACTOSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; PROMOTER REGIONS, GENETIC; SACCHAROMYCES CEREVISIAE;

FILOBASIDIELLA NEOFORMANS;

EID: 57649240401     PISSN: 10871845     EISSN: 10960937     Source Type: Journal    
DOI: 10.1016/j.fgb.2008.10.003     Document Type: Article

References (34)

1. Banerjee U., Datta K., Majumdar T., and Gupta K. Cryptococcosis in India: the awakening of a giant?. Med. Mycol. 39 (2001) 51-67
2. Bar-Peled M., Griffith C.L., and Doering T.L. Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc. Natl. Acad. Sci. USA 98 21 (2001) 12003-12008
3. Bose I., Reese A.J., Ory J.J., Janbon G., and Doering T.L. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2 4 (2003) 655-663
4. Casadevall A., and Perfect J.R. Cryptococcus neoformans (1998), American Society for Microbiology, Washington, DC
5. Davidson R., Blankenship J., Kraus P., Berrios M., Hull C., D'Souza C., Wang P., and Heitman J. A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 138 8 (2002) 2607-2615
6. del Poeta M., Toffaletti D.L., Rude T.H., Sparks S.D., Heitman J., and Perfect J.R. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein. Infect. Immun. 67 4 (1999) 1812-1820
7. Edman J.C., and Kwon-Chung K.J. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10 (1990) 4538-4544
8. Fujimura H., and Sakuma Y. Simplified isolation of chromosomal and plasmid DNA from yeasts. Biotechniques 14 4 (1993) 538-540
9. Gerik K.J., Bhimireddy S.R., Ryerse J.S., Specht C.A., and Lodge J.K. Protein kinase C1 (PKC1) is essential for protection against both oxidative and nitrosative stress, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell. 7 (2008) 1685-1698
10. Gerik K.J., Donlin M.J., Soto C.E., Banks A.M., Banks I.R., Maligie M.A., Selitrennikoff C.P., and Lodge J.K. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol. Microbiol. 58 2 (2005) 393-408
11. Gorlach J.M., McDade H.C., Perfect J.R., and Cox G.M. Antisense repression in Cryptococcus neoformans as a laboratory tool and potential antifungal strategy. Microbiology 148 1 (2002) 213-219
12. Hua J., Meyer J., and Lodge J. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 7 1 (2000) 125-128
13. Hull C.M., and Heitman J. Genetics of Cryptococcus neoformans. Annu. Rev. Genet. 36 (2002) 557-615
14. Johnston M. A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 51 4 (1987) 458-476
15. Kwon-Chung K.J., and Bennett J.E. Distrubution of α and a mating types of Cryptococcus neoformans among natural and clinical isolates. Am. J. Epidemiol. 108 4 (1978) 337-340
16. Leloir L.F. Enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Arch. Biochem. 33 (1951) 186-190
17. Lengeler K.B., Wang P., Cox G.M., Perfect J.R., and Heitman J. Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct. Proc. Natl. Acad. Sci. USA 97 26 (2000) 14455-14460
18. Liu H., Cottrell T.R., Pierini L.M., Goldman W.E., and Doering T.L. RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics 160 2 (2002) 463-470
19. Lodge J.K., Jackson-Machelski E., Higgins M., McWherter C.A., Sikorski J.A., Devadas B., and Gordon J.I. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent. J. Biol. Chem. 273 20 (1998) 12482-12491
20. Lodge J.K., Jackson-Machelski E., Toffaletti D.L., Perfect J.R., and Gordon J.I. Targeted gene replacement demonstrates that myristoyl-CoA:protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. PNAS 91 25 (1994) 12008-12012
21. Loftus B.J., Fung E., Roncaglia P., Rowley D., Amedeo P., Bruno D., Vamathevan J., Miranda M., Anderson I.J., Fraser J.A., Allen J.E., Bosdet I.E., Brent M.R., Chiu R., Doering T.L., Donlin M.J., D'Souza C.A., Fox D.S., Grinberg V., Fu J., Fukushima M., Haas B.J., Huang J.C., Janbon G., Jones S.J.M., Koo H.L., Krzywinski M.I., Kwon-Chung J.K., Lengeler K.B., Maiti R., Marra M.A., Marra R.E., Mathewson C.A., Mitchell T.G., Pertea M., Riggs F.R., Salzberg S.L., Schein J.E., Shvartsbeyn A., Shin H., Shumway M., Specht C.A., Suh B.B., Tenney A., Utterback T.R., Wickes B.L., Wortman J.R., Wye N.H., Kronstad J.W., Lodge J.K., Heitman J., Davis R.W., Fraser C.M., and Hyman R.W. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307 5713 (2005) 1321-1324
22. McDade H., and Cox G. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39 1 (2001) 151-154
23. Moyrand F., Fontaine T., and Janbon G. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64 3 (2007) 771-781
24. Nielsen K., Cox G.M., Wang P., Toffaletti D.L., Perfect J.R., and Heitman J. Sexual cycle of Cryptococcus neoformans var Grubii and virulence of congenic a and alpha isolates. Infect. Immun. 71 9 (2003) 4831-4841
25. Oh D., and Hopper J.E. Transcription of a yeast phosphoglucomutase isozyme gene is galactose inducible and glucose repressible. Mol. Cell. Biol. 10 4 (1990) 1415-1422
26. Ory J.J., Griffith C.L., and Doering T.L. An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast 21 11 (2004) 919-926
27. Perfect J.R., Toffaletti D.L., and Rude T.H. The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect. Immun. 61 10 (1993) 4446-4451
28. Sambrook J., and Russell D. Molecular Cloning: A Laboratory Manual. third ed. (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. Thompson J.R., Douglas C.M., Li W., Jue C.K., Pramanik B., Yuan X., Rude T.H., Toffaletti D.L., Perfect J.R., and Kurtz M. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J. Bacteriol. 181 2 (1999) 444-453
30. Toffaletti D.L., Rude T.H., Johnston S.A., Durack D.T., and Perfect J.R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175 5 (1993) 1405-1411
31. Torchia T.E., Hamilton R.W., Cano C.L., and Hopper J.E. Disruption of regulatory gene GAL80 in Saccharomyces cerevisiae: effects on carbon-controlled regulation of the galactose/melibiose pathway genes. Mol. Cell. Biol. 4 8 (1984) 1521-1527
32. Torchia T.E., and Hopper J.E. Genetic and molecular analysis of the GAL3 gene in the expression of the galactose/melibiose regulon of Saccharomyces cerevisiae. Genetics 113 2 (1986) 229-246
33. Tschopp J.F., Emr S.D., Field C., and Schekman R. GAL2 codes for a membrane-bound subunit of the galactose permease in Saccharomyces cerevisiae. J. Bacteriol. 166 1 (1986) 313-318
34. Wickes B.L., and Edman J.C. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol. Microbiol. 16 (1995) 1099-1109